News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • TSMC shares pulled back amid semiconductor volatility, flagged as a buying opportunity.
  • TSMC reports AI and HPC-driven revenue growth.
  • TSMC maintains industry-leading profit margins.
  • TSMC's market capitalization stands near $2.18 trillion.
  • Analyst suggests a 45-trading-day swing trade: entry $421, target $470, stop $395.
  • Broad semiconductor sector volatility continues to pressure chip stocks.

Latest Articles

Optical Cable Shares Jump After Q3 Results Beat Expectations

Optical Cable Shares Jump After Q3 Results Beat Expectations

Optical Cable Corporation stock climbed about 12.8% in pre-market trading after the Roanoke, Virginia-based manufacturer of fiber optic and copper cabling reported third-quarter fiscal 2026 results ahead of an 11:00 a.m. ET investor call. Analysts had expected $0.20 in earnings per share and roughly $24.5 million in revenue for the quarter, and the…

Sinopec Forecasts Sharp Slide in China’s Oil Demand in 2026

Sinopec Forecasts Sharp Slide in China’s Oil Demand in 2026

Sinopec’s Economics & Development Research Institute projects China’s oil demand will fall by 600,000 barrels per day in 2026, an 8.9% year-over-year decline, driven by elevated crude prices and accelerating electric vehicle adoption. The institute says demand peaked in 2025 and provides long-range estimates through 2060, while noting changes in re…

InnovAge Jumps After Strong Fiscal 2026 Results and Bullish 2027 Guidance

InnovAge Jumps After Strong Fiscal 2026 Results and Bullish 2027 Guidance

InnovAge shares jumped 14.6% in pre-open trading after the company reported fiscal fourth-quarter and full-year 2026 results that showed a substantial turnaround. Adjusted EBITDA rose roughly 175% to $94.6 million, revenue climbed 15.9% to $989.7 million, and net loss narrowed to $0.7 million. Management provided fiscal 2027 guidance that targets c…

Market Ripples as Oil Tops $100 Again and U.S.-Canada Trade Escalates

Market Ripples as Oil Tops $100 Again and U.S.-Canada Trade Escalates

Renewed hostilities in the Middle East have driven Brent crude back above $100 per barrel and lifted natural gas to three-year highs, while a sharp escalation in U.S.-Canada trade measures adds to market pressure. Global markets are reacting to higher energy costs, increased long-term borrowing rates and currency moves ahead of anticipated central …

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind Corporation has entered into a licensing and collaboration agreement with Rose Pharma Inc. to develop ROSE-010 Technosphere, a rapid-acting, short-duration inhaled GLP-1 receptor agonist for weight management. MannKind will provide pharmaceutical development and manufacturing support through Phase 1b trials, receive equity in Rose Pharma, …

Einride Expands Defense Offering With Mission Planning and Operational Decision-Making for Autonomous Logistics

Einride Expands Defense Offering With Mission Planning and Operational Decision-Making for Autonomous Logistics

Einride AB announced a strategic partnership with UNIQAI Systems to enhance its autonomous logistics platform with AI-driven mission planning and operational decision-making capabilities tailored for defense and national security clients. Building on its existing autonomous freight technology and previous collaborations, Einride aims to address a s…

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Telix Pharmaceuticals Limited announced that its senior executives will present at the Morgan Stanley 24th Annual Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company, a global radiopharmaceutical leader in cancer theranostics, aims to showcase its commercial progress and future plans to investo…

Pound softens as dollar steadies after earlier weakness

Pound softens as dollar steadies after earlier weakness

Sterling slipped marginally on Wednesday while the euro held steady as the dollar recovered some footing after a broad decline in the prior session. Market commentary from ING highlights puzzling dollar behavior, the potential role of energy-driven trade flows, and the key influence of USD/JPY and upcoming U.S. CPI and ECB moves on currency directi…

Starbucks’ Niccol Restored Traffic but Profit Margins Remain the Next Test

Starbucks’ Niccol Restored Traffic but Profit Margins Remain the Next Test

Under Brian Niccol’s two-year tenure, Starbucks has reversed several quarters of falling comparable sales by investing in staffing, store upgrades and marketing. Those moves have driven a sustained sales recovery but increased operating costs have compressed margins, particularly in North America. Management has signaled a shift toward efficiency w…